These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 31252648)

  • 1. Circulating microRNAs as Promising Biomarkers in Colorectal Cancer.
    Rapado-González Ó; Álvarez-Castro A; López-López R; Iglesias-Canle J; Suárez-Cunqueiro MM; Muinelo-Romay L
    Cancers (Basel); 2019 Jun; 11(7):. PubMed ID: 31252648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. microRNA biomarkers in colorectal cancer liver metastasis.
    Huang S; Tan X; Huang Z; Chen Z; Lin P; Fu SW
    J Cancer; 2018; 9(21):3867-3873. PubMed ID: 30410589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic Landscape of Liquid Biopsy in Colorectal Cancer.
    Rodriguez-Casanova A; Costa-Fraga N; Bao-Caamano A; López-López R; Muinelo-Romay L; Diaz-Lagares A
    Front Cell Dev Biol; 2021; 9():622459. PubMed ID: 33614651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common molecular markers between circulating tumor cells and blood exosomes in colorectal cancer: a systematic and analytical review.
    Vafaei S; Fattahi F; Ebrahimi M; Janani L; Shariftabrizi A; Madjd Z
    Cancer Manag Res; 2019; 11():8669-8698. PubMed ID: 31576171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating biomarkers for early detection and clinical management of colorectal cancer.
    Marcuello M; Vymetalkova V; Neves RPL; Duran-Sanchon S; Vedeld HM; Tham E; van Dalum G; Flügen G; Garcia-Barberan V; Fijneman RJ; Castells A; Vodicka P; Lind GE; Stoecklein NH; Heitzer E; Gironella M
    Mol Aspects Med; 2019 Oct; 69():107-122. PubMed ID: 31189073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and biological significance of circulating tumor cells, circulating tumor DNA, and exosomes as biomarkers in colorectal cancer.
    Jia S; Zhang R; Li Z; Li J
    Oncotarget; 2017 Aug; 8(33):55632-55645. PubMed ID: 28903450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetics of colorectal cancer: emerging circulating diagnostic and prognostic biomarkers.
    Danese E; Montagnana M
    Ann Transl Med; 2017 Jul; 5(13):279. PubMed ID: 28758105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A panel of serum exosomal microRNAs as predictive markers for chemoresistance in advanced colorectal cancer.
    Jin G; Liu Y; Zhang J; Bian Z; Yao S; Fei B; Zhou L; Yin Y; Huang Z
    Cancer Chemother Pharmacol; 2019 Aug; 84(2):315-325. PubMed ID: 31089750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid Biopsy and Circulating Biomarkers for the Diagnosis of Precancerous and Cancerous Oral Lesions.
    Gattuso G; Crimi S; Lavoro A; Rizzo R; Musumarra G; Gallo S; Facciponte F; Paratore S; Russo A; Bordonaro R; Isola G; Bianchi A; Libra M; Falzone L
    Noncoding RNA; 2022 Aug; 8(4):. PubMed ID: 36005828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosome-encapsulated microRNAs as circulating biomarkers for colorectal cancer.
    Yan S; Han B; Gao S; Wang X; Wang Z; Wang F; Zhang J; Xu D; Sun B
    Oncotarget; 2017 Sep; 8(36):60149-60158. PubMed ID: 28947960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New trends in molecular and cellular biomarker discovery for colorectal cancer.
    Aghagolzadeh P; Radpour R
    World J Gastroenterol; 2016 Jul; 22(25):5678-93. PubMed ID: 27433083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs: Potential candidates for diagnosis and treatment of colorectal cancer.
    Moridikia A; Mirzaei H; Sahebkar A; Salimian J
    J Cell Physiol; 2018 Feb; 233(2):901-913. PubMed ID: 28092102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-6869-5p acts as a tumor suppressor via targeting TLR4/NF-κB signaling pathway in colorectal cancer.
    Yan S; Liu G; Jin C; Wang Z; Duan Q; Xu J; Xu D
    J Cell Physiol; 2018 Sep; 233(9):6660-6668. PubMed ID: 29206292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs: Novel immunotherapeutic targets in colorectal carcinoma.
    Li X; Nie J; Mei Q; Han WD
    World J Gastroenterol; 2016 Jun; 22(23):5317-31. PubMed ID: 27340348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating MicroRNAs: Valuable Biomarkers for the Diagnosis and Prognosis of Gastric Cancer.
    Shekari N; Baradaran B; Shanehbandi D; Kazemi T
    Curr Med Chem; 2018 Feb; 25(6):698-714. PubMed ID: 28971758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of miRNA-210, miRNA-21 and miRNA-126 as diagnostic biomarkers in colorectal carcinoma: impact of HIF-1α-VEGF signaling pathway.
    Sabry D; El-Deek SEM; Maher M; El-Baz MAH; El-Bader HM; Amer E; Hassan EA; Fathy W; El-Deek HEM
    Mol Cell Biochem; 2019 Apr; 454(1-2):177-189. PubMed ID: 30357530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and prognostic biomarkers in colorectal cancer and the potential role of exosomes in drug delivery.
    Sattar RSA; Verma R; Nimisha ; Kumar A; Dar GM; Apurva ; Sharma AK; Kumari I; Ahmad E; Ali A; Mahajan B; Saluja SS
    Cell Signal; 2022 Nov; 99():110413. PubMed ID: 35907519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive and prognostic biomarkers in colorectal cancer: A systematic review of recent advances and challenges.
    Das V; Kalita J; Pal M
    Biomed Pharmacother; 2017 Mar; 87():8-19. PubMed ID: 28040600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Dual Role of MicroRNAs in Colorectal Cancer Progression.
    Ding L; Lan Z; Xiong X; Ao H; Feng Y; Gu H; Yu M; Cui Q
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30227605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquid biopsy approaches and immunotherapy in colorectal cancer for precision medicine: Are we there yet?
    Mirza S; Bhadresha K; Mughal MJ; McCabe M; Shahbazi R; Ruff P; Penny C
    Front Oncol; 2022; 12():1023565. PubMed ID: 36686736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.